Correspondence re: L. E. Damon et al., Plasma and Cerebrospinal Fluid Pharmacokinetics of 1-β-d-Arabinofuranosylcytosine and 1-β-d-Arabinofuranosyluracil following the Repeated Intravenous Administration of High- and Intermediate-Dose 1-β-d-Arabinofuranosylcytosine. Cancer Res., 51: 4141–4145, 1991.

Kreis, Willi; Budman, Daniel R.

Correspondence re: L. E. Damon et al., Plasma and Cerebrospinal Fluid Pharmacokinetics of 1-β-d-Arabinofuranosylcytosine and 1-β-d-Arabinofuranosyluracil following the Repeated Intravenous Administration of High- and Intermediate-Dose 1-β-d-Arabinofuranosylcytosine. Cancer Res., 51: 4141–4145, 1991.^¹

Willi Kreis, M.D.;

Willi Kreis, M.D.

Don Monti Division of Oncology Department of Medicine North Shore University Hospital Cornell University Medical College

Manhasset, New York 11030

Search for other works by this author on:

This Site

PubMed

Google Scholar

Daniel R. Budman, M.D.

Don Monti Division of Oncology Department of Medicine North Shore University Hospital Cornell University Medical College

Manhasset, New York 11030

Search for other works by this author on:

This Site

PubMed

Google Scholar

Received: October 25 1991

Accepted: April 24 1992

Online ISSN: 1538-7445

Print ISSN: 0008-5472

1992

Cancer Research, Inc.

Cancer Res (1992) 52 (13): 3818–3819.

Article PDF first page preview

Contents

Data & Figures

Supplements

References

Citing articles via

Email alerts

AACR Journals